(Q33721389)

English

Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

renal cell carcinoma

1 reference

based on heuristic

inferred from title

object named as

Urania Dafni

18

0 references

Athanasios Dimopoulos

object named as

Meletios A Dimopoulos

20

0 references

George Fountzilas

19

object named as

George Fountzilas

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Aristotelis Bamias

1

object named as

Aristotelis Bamias

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Eleni Timotheadou

6

object named as

Eleni Timotheadou

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

5

object named as

Lia Malettou

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Christos N Papandreou

16

object named as

Christos Papandreou

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

3

object named as

Sofia Lampaki

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Christos Christodoulou

14

object named as

Christos Christodoulou

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Alexandra Karadimou

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

George Lainakis

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Kostas Papazisis

7

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Charalambos Andreadis

8

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Loukas Kontovinis

9

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Ioannis Anastasiou

10

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Kostas Stravodimos

11

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Ioannis Xanthakis

12

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Andreas Skolarikos

13

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Kostas Syrigos

15

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Evangelia Razi

17

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

language of work or name

0 references

publication date

18 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

45

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837011

21 June 2018

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837011

21 June 2018

Toxicities associated with the administration of sorafenib, sunitinib, and temsirolimus and their management in patients with metastatic renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837011

21 June 2018

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837011

21 June 2018

Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837011

21 June 2018

Sunitinib: from rational design to clinical efficacy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837011

21 June 2018

Sorafenib in advanced clear-cell renal-cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837011

21 June 2018

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837011

21 June 2018

Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837011

21 June 2018

Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837011

21 June 2018

Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837011

21 June 2018

Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837011

21 June 2018

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837011

21 June 2018

Resection of metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-45

21 January 2018

Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-45

21 January 2018

Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837011

30 October 2018

Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20163744

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20163744

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-10-45

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33721389&oldid=2195692602"